The LDHAL6A Polyclonal Antibody (PACO10218) is a crucial tool for researchers studying LDHAL6A, a key enzyme involved in lactate dehydrogenase regulation. This antibody, generated in rabbits, exhibits high reactivity with human samples and is specifically validated for Western blot applications. By binding to the LDHAL6A protein, this antibody enables accurate detection and analysis in various cell types, making it an essential asset for studies in metabolism and cancer research.LDHAL6A is known to play a crucial role in glycolysis and lactate metabolism, making it a potential target for therapeutic interventions in metabolic disorders and cancer.
Understanding the function and regulation of LDHAL6A is essential for developing effective treatments that target metabolic pathways in disease states. The LDHAL6A Polyclonal Antibody provides researchers with a reliable tool to explore the role of this enzyme in health and disease, offering new insights into metabolic pathways and potential therapeutic strategies.
